據Axios：一位美國官員表示，“如果明天他們（伊朗）不作出相關表態，那明天對他們來說可不會是個好日子。”

China A-share short-form drama and gaming sector surged; stocks including Zhewen Hulian and Zhongke Jincai hit daily limit-up. Rongxin Culture rose over 11%, Yidian Tianxia gained more than 9% and Xingfu Lanhai climbed about 7%.

July 10 — Novo Nordisk China said the NMPA approved a label update for oral semaglutide tablets (brand: Rybelsus). The drug, approved in China for glycaemic control in adults with type 2 diabetes, had its label revised based on the SOUL trial primary results, which showed a 14% reduction in major adverse cardiovascular events (MACE) in adults with type 2 diabetes and established cardiovascular disease and/or chronic kidney disease.